Abstracts

Poster Presentation Dates

All odd numbered posters will be presented on Friday, November 8, 2019, while even numbered posters will be presented on Saturday, November 9, 2019.

Posters will be on display from 7 a.m. - 8 p.m., with the presenting authors required to be at their posters during lunch (12:30 - 2 p.m. on Friday, Nov. 8, and 12:35 - 2:05 p.m. on Saturday, Nov. 9) and also during the poster reception (6:30 - 8p.m. on Friday, Nov. 8, and 7 - 8:30 p.m. on Saturday, Nov. 9).

#	Title	Authors	Category	Keywords
P831	Inclusion of people living with HIV in anti-PD(L)1 clinical trials: Results of an NCI-driven initiative to broaden eligibility in clinical trial development	Joshua E. Reuss, MD; Diana Stern, MD; Ramya Ramaswami; Kathryn Lurain, MD; Helen Chen, MD; Howard Streicher, MD; Ravie Kem, RPh, Pharm D, MPH; Richard F. Little, MD; Elad Sharon, MD, MPH;	Regulatory, Financial, and Access Considerations	Checkpoint blockade; Clinical trial
P832	Systematic literature review (SLR) of intravenously (IV) administered oncology therapies for which a subcutaneous (SC) formulation has also been developed	Brad Schenkel, MSc; Elise Wu; Ali McBride; Marília Hernani; Robin Wyn; Klaudia Kornalska;	Regulatory, Financial, and Access Considerations	Clinical study; Targeted therapy